Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization
Xiaolu Ma, Xu-Dong Qu, Wenjing Yang, Beili Wang, Minna Shen, Yan Zhou, Chunyan Zhang, Yun‐Fan Sun, Jianwen Chen, Bo Hu, Zijun Gong, Xin Zhang, Baishen Pan, Jian Zhou, Jia Fan, Xin‐Rong Yang, Wei Guo
Topics & Concepts
Hepatocellular carcinomaMedicineGastroenterologyImmunosuppressionInternal medicineTranscatheter arterial chemoembolizationCD163CD68Proportional hazards modelImmunohistochemistryMacrophageBiochemistryChemistryIn vitroHepatocellular Carcinoma Treatment and PrognosisCell death mechanisms and regulationCancer Immunotherapy and Biomarkers